Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Isracann Biosciences Inc (IPOT.CN)

Isracann Biosciences Inc (IPOT.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 2,640
  • Shares Outstanding, K 175,990
  • Annual Sales, $ 0 K
  • Annual Income, $ -4,693 K
  • 60-Month Beta 0.16
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 20.60
Trade IPOT.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings $0.00 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0100 +50.00%
on 04/03/23
0.0200 -25.00%
on 03/31/23
unch (unch)
since 03/03/23
3-Month
0.0100 +50.00%
on 04/03/23
0.0200 -25.00%
on 03/31/23
unch (unch)
since 01/06/23
52-Week
0.0100 +50.00%
on 04/03/23
0.0800 -81.25%
on 06/03/22
-0.0650 (-81.25%)
since 04/06/22

Most Recent Stories

More News
Stocks in play: Isracann Biosciences Inc

Announced it has signed its first distribution agreement in Canada, for Praesidio Health products with ...

IPOT.CN : 0.0150 (unch)
Isracann Biosciences Announces Closing of First Tranche of $0.05 Unit Private Placement

VANCOUVER, British Columbia, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is...

IPOT.CN : 0.0150 (unch)
ISCNF : 0.0001 (-90.00%)
Isracann Biosciences Subsidiary Praesidio Health Submits NPNs to Health Canada

VANCOUVER, British Columbia, May 19, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) a...

IPOT.CN : 0.0150 (unch)
ISCNF : 0.0001 (-90.00%)
Isracann Biosciences Renews Leadership to Meet Changing Demands

VANCOUVER, British Columbia, April 15, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is...

IPOT.CN : 0.0150 (unch)
ISCNF : 0.0001 (-90.00%)
Stocks in play: Isracann Biosciences Inc

Announces that, further to the Company’s news releases dated February 23, 2022 and March 28, 2022, it ...

IPOT.CN : 0.0150 (unch)
Isracann Biosciences Acquires Natural Health Medicine Developer and Appoints Natural Health Products Officers

VANCOUVER, British Columbia, April 13, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is...

IPOT.CN : 0.0150 (unch)
ISCNF : 0.0001 (-90.00%)
Isracann Biosciences Signs Definitive Agreement to Acquire Natural Health Medicine Developer

VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is...

IPOT.CN : 0.0150 (unch)
ISCNF : 0.0001 (-90.00%)
UPDATE - Isracann Signs LOI to Acquire Natural Health Medicine Developer

VANCOUVER, British Columbia, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or...

IPOT.CN : 0.0150 (unch)
ISCNF : 0.0001 (-90.00%)
Isracann Signs LOI to Acquire Natural Health Medicine Developer

VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or...

IPOT.CN : 0.0150 (unch)
ISCNF : 0.0001 (-90.00%)
Isracann Advises on Recent Activities and 2022 Outlook

VANCOUVER, British Columbia, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or...

IPOT.CN : 0.0150 (unch)
ISCNF : 0.0001 (-90.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.0150
2nd Resistance Point 0.0150
1st Resistance Point 0.0150
Last Price 0.0150
1st Support Level 0.0150
2nd Support Level 0.0150
3rd Support Level 0.0150

See More

52-Week High 0.0800
Fibonacci 61.8% 0.0533
Fibonacci 50% 0.0450
Fibonacci 38.2% 0.0367
Last Price 0.0150
52-Week Low 0.0100

See More

Business Summary

Isracann Biosciences Inc is a pure-play cannabis company engaged in producing cannabis products. The company is engaged in the cultivation, manufacturing, distribution, and branding of medical cannabis-based products.

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar